Research And Markets - Nuclear Receptors: The Market For Nuclear Receptor Targeted Drugs Is Estimated To Be 10-15% Of The $400 Billion Global Pharmaceutical Market

Research and Markets (researchandmarkets.com/reports/c9248) has announced the addition of Nuclear Receptors: Key Targets for New Pharmaceuticals to their offering.

(PRWEB) November 18, 2004 -- Nuclear receptors are a family of proteins involved in key metabolic processes with great potential as targets for the treatment of significant diseases such as cancer, coronary heart disease, and diabetes. Collectively these diseases represent a large market for prescription drugs worldwide. The nuclear receptor family contains a large group of transcription factors, with 49 members presently identified in the human genome. Nuclear receptors are attractive targets for drug discovery because those that have been discovered thus far have proved to be "druggable", in other words, their activity can be modulated by small molecules.

Research and Markets (http://www.researchandmarkets.com/reports/c9248) has announced the addition of Nuclear Receptors: Key Targets for New Pharmaceuticals to their offering.

This Nuclear Receptors Market Analysis Report describes the key members of the nuclear receptor family and discusses their potential as drug targets. In addition, the Report provides an overview of nuclear receptor physiology, highlighting the potential of each receptor as a target for pharmaceutical development

Market Opportunities
-Development of a new generation of nuclear receptor targeting drugs using the information gained from this large family of transcription factors.
- Targeting underserved markets through the development of pharmaceuticals that change the activity of orphan receptors.
- Development of highly selective therapeutics designed to alter the tissue specific expression of nuclear receptor regulated genes.

Key Reasons to Buy this report:
- Discover the commercial potential of nuclear receptors through an assessment of the current and potential market for drugs targeting major diseases such as cancer, diabetes, and obesity.
- Gain an understanding of nuclear receptor controlled pathways and how the modulation of these pathways forms a target for rational drug design with an overview of what is known about each receptor and how they impact disease processes.
- Discover the impact of nuclear receptors on drug development via an in-depth analysis of recent discoveries and applications.
- Learn about the potential of nuclear receptors as drug targets from reliable and thought-provoking interviews with authorities involved in this industry.
- Focus on the primary companies engaged in nuclear receptors with in-depth profiles of their technologies, financial and partnering activities, pipelines, and more.

The contents of this report are as follows:
1 Executive Summary
2 The Nuclear Receptor Family
3 Disorders of Lipid Homeostasis
4 Cancer
5 Inflammatory Disease
6 Additional Clinical Opportunities for Nuclear Receptor Targeting
7 "In my Opinion": Comments from the Experts
8 Company Profiles
9 Future Prospects
10 Additional Reading

For more information visit http://www.researchandmarkets.com/reports/c9248

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###